Tag: Michael Frank

January 12, 2021

Psychedelics Stocks to Watch

A growing list of the available psychedelics stocks to watch out for from the Investing News Network.
May 13, 2020

Revive Therapeutics Provides Corporate Update on its Pharmaceutical Initiatives

Revive Therapeutics is pleased to provide a corporate update on its pharmaceutical programs for Bucillamine in the treatment of the...
April 29, 2020

Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program

Revive Therapeutics is pleased to provide further insight on its plans for its psilocybin-based pharmaceutical program.
April 23, 2020

Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial

Revive Therapeutics (CSE:RVV) has received positive feedback from the U.S. FDA in response to the company’s pre-IND meeting that was...
April 21, 2020

Revive Therapeutics Announces Research Partnership Agreement with the University of Wisconsin-Madison

Revive Therapeutics (CSE:RVV) has entered into a SRPA with the University of Wisconsin-Madison to evaluate novel formulations and drug delivery...
April 17, 2020

Revive Therapeutics Partners with Complete Phytochemical Solutions to Advance Research Initiatives for Psilocybin-Based Pharmaceutical Products

Revive Therapeutics (CSE:RVV) has engaged Complete Phytochemical Solutions to advance the Company’s research and development initiatives of psilocybin-based products for...
April 15, 2020

Revive Therapeutics Announces Closing of Second Tranche of Brokered Private Placement

Revive Therapeutics (CSE:RVV) has issued an additional 16,400,000 units at a price of $0.05 per Unit for gross proceeds of...